The objective of this study was to investigate the sanitary and management characteristics of live-bird resellers as well as identify and undertake an antigenic characterization of Salmonella enterica and its sensitivity to antimicrobials. Structured questionnaires were applied and 627 samples were collected from the cages, consisting 209 samples of excreta, 209 of feed and 209 drinker swabs. These were processed by conventional bacteriology. The obtained isolates were subjected to the susceptibility test and to 12 antimicrobial tests by the disk diffusion method. Of the studied resellers, 91.7% house Gallus gallus domesticus, together with other animal species; sell birds with little zoosanitary documentation; have unsatisfactory active surveillance; and use and sell antimicrobials indiscriminately. The presence of Salmonella enterica was detected in 1.4% (9/627) of the samples analyzed in the cages, with 1.9% (4/209) found in excreta, 0.95% (2/209) in feed and in 1.4% (3/209) in drinker swabs. These were characterized antigenically as Salmonella Heidelberg, Gallinarum, Risen, Ndolo, Saint Paul, Mbandaka and subsp enterica O:6,7. When susceptibility to antimicrobials was determined, 44.4% resistance (4/9) was detected for trimethoprim-sulfamethoxazole, 33.3% (3/9) for enrofloxacin, 22.2% (2/9) for ciprofloxacin, ceftiofur and amoxicillin and 11.1% (1/9) for tetracycline and fosfomycin. Salmonella Heidelberg, as well as serovars Gallinarum, Risen, Saint Paul and Mbandaka, showed resistance to at least one of the tested antimicrobials. Trimethoprim-sulfamethoxazole and enrofloxacin were the antimicrobials that showed the least efficacy. Serovars such as Heidelberg, Gallinarum and Mbandaka have multiresistance to antimicrobials commonly used in human and veterinary medicine, implying potential risks to One Health.

Captive Psittaciformes may harbor Gram-negative bacteria in their digestive tract, mainly due to poor hygienic conditions and confinement. The present study was carried out with the objective of isolating and identifying Escherichia coli in samples collected from Psittaciformes cages in 50 commercial establishments in the metropolitan region of Goiania, with subsequent antimicrobial susceptibility testing and detection of virulence genes. A total of 141 samples of excreta and swab samples from feeders and water bowls were collected, totaling 423 samples. Escherichia coli was isolated from 9.7% (41/423) samples: 12% (17/141) in excreta, 8.5% (12/141) in feed, and 8.5% (12 /141) in waterers. To determine the susceptibility profile of E. coli isolates, resistance to ciprofloxacin 4.9% (2/41), gentamicin 17.0% (7/41), doxycycline 34.1% (14/41), florfenicol 34.1% (14/41), trimethoprim 39.0% (16/41), tetracycline 41.5% (17/41), enrofloxacin 43.9% (18/41), amoxicillin 48.8% (20/41), neomycin 61.0% (25/41), and sulfonamide 90.2% (37/41) was determined. In 20 isolates, resistance was determined at 4 or more antimicrobials, seven of excreta (7/17), five of feed (5/12), and eight of waterers (8/12). One of the isolates from the waterers showed resistance to all antimicrobials. The iss gene was detected in three isolates, the tsh gene in three, the papC gene in two, traT and eae genes were not detected. In this study, it can be concluded that Psittaciformes commercialized as pet are carry E. coli isolates resistant to most commonly used antimicrobials, mainly sulfonamides and neomycin, besides having virulence and serum resistance genes, which highlights the possibility of the to cause disease in humans.